Market Tracker

11/28 1:06pm ET

ProPhase Labs Inc (NASDAQ:PRPH)

1.43
Data as of 12:44pm ET
 +0.01 / +0.70%
Today’s Change
1.21
Today|||52-Week Range
2.98
-11.18%
Year-to-Date
No recent news for ProPhase Labs Inc.

Today’s Trading

Previous close1.42
Today’s open1.44
Day’s range1.39 - 1.44
Volume3,178
Average volume (3 months)27,115
Market cap$22.0M
Dividend yield--
Data as of 12:44pm ET, 11/28/2014

Growth & Valuation

Earnings growth (last year)--
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)+11.72%
P/E ratioNM
Price/Sales1.02
Price/Book1.82

Competitors

 Today’s
change
Today’s
% change
CBLICleveland Biolabs In...-0.02-5.00%
NYMXNymox Pharmaceutical...-0.05-8.12%
--RepliCel Life Scienc...+0.02+7.36%
REPHRecro Pharma Inc-0.05-1.85%
Data as of 12:50pm ET, 11/28/2014

Financials

Last reporting date--
EPS forecast (this quarter)--
Annual revenue (last year)$25.0M
Annual profit (last year)$405.0K
Net profit margin1.62%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
Chairman, CEO &
Head-Investor Relations
Ted William Karkus
Executive VP, Chief Operating &
Financial Officer
Robert V. Cuddihy
Corporate headquarters
Doylestown, Pennsylvania

Forecasts